A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.
A new endovascular sonic lysis system reduces the risk of hemorrhage by dissolving clots faster than conventional catheter thrombolysis or mechanically assisted thrombectomy devices.
Dr. Constantino Peña, an interventional radiologist at the Baptist Cardiac & Vascular Institute in Miami, showed how the procedure works during a live televised case demonstration at the 2009 International Symposium on Endovascular Therapy. A 74- year-old patient with a blocked leg artery underwent ultrasound-enhanced thrombolysis with a tenecteplase/heparin infusion.The procedure required only half the usual thrombolytic dose and ended with a dissolved clot 12 hours later. Other techniques need at least 24 hours to be effective, which heightens bleeding risks associated with thrombolytics. BCVI specialists have performed the procedure on more than 100 patients using this technique, Peña said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.